TrialThe oncologist2015

Comparative effectiveness of mitoxantrone plus prednisone versus prednisone alone in metastatic castrate-resistant prostate cancer after docetaxel failure.

Angela K Green et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.